Top

A Novel Early Relapse Prediction Score Based on Age, ISS and Disease Status at the Time of Transplant in Patients with Newly Diagnosed Multiple Myeloma. A Study of the EBMT Chronic Malignancies Working Party

Type d'étude:

Retrospective Studies

Numéro de l'étude:

42206691

Type de traitement:

Autologous

Maladies:

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Titre court:

Objectif principal:

To develop a scoring system that will enable prediction of of early relapse within 12 months of AHSCT-1 among patients newly diagnosed with Multiple Myeloma

Principaux critères d'inclusion:

Newly diagnosed patients with multiple myeloma having received an AHCT-1 between 2008-2018

Pays:

Investigateur principal:

Meral Beksac

Coordinateur EBMT de l'étude:

Linda Koster

E-mail du coordinateur de l'étude:

cmwpebmt@lumc.nl